Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...

The Trump administration announced its newest pharmaceutical agreement under its Most Favored Nation policy Thursday, ...

U.S. President Donald Trump, Eli Lilly and Novo Nordisk unveiled a deal on Thursday to slash the prices of popular GLP-1 ...

President Donald Trump’s administration confirmed Thursday that it has reached a deal with Eli Lilly and Novo Nordisk that ...

The deals are among the most politically significant announcements to date in the Trump administration's efforts to rein in ...

Eli Lilly and Novo Nordisk are cutting prices for popular weight-loss drugs in deals struck with the Trump administration, ...

Shares in Novo Nordisk fell at opening on Friday, after the Wegovy-maker and rival Eli Lilly struck a deal late on Thursday with U.S. President Donald Trump to slash prices of their GLP-1 weight-loss ...

The deal is with drugmakers Eli Lilly and Novo Nordisk to cut prices of their weight-loss drugs and expand Medicare coverage ...

Popular GLP-1 drugs like Ozempic will get cheaper in exchange for partial Medicare coverage, opening up new markets for Eli ...

President Trump, Lilly, and Novo Nordisk agree to lower prices of GLP-1 weight-loss drugs for Medicare, Medicaid, and cash ...

Obesity medicines coverage in U.S. Medicare Part D via a pilot programme, starting during 2026Introduction of lower prices ...

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...